This message was sent to ##Email##
|
|
|
2019 ACS Quality and Safety Conference scholarships for cancer registrars: APPLY NOW!
|
   |
The American College of Surgeons (ACS) Cancer Programs is pleased to offer a limited number of scholarships to cancer registrars who are interested in attending the upcoming ACS Quality and Safety Conference taking place at the Walter E. Washington Convention Center in Washington, DC, July 19–22. This scholarship award of $1,000 can be used to cover conference registration, travel and hotel expenses. The award will be paid following confirmation of conference attendance. Applicants must be a cancer registrar at an ACS Cancer Programs-accredited institution.
Applications must include:
- A letter of recommendation from your supervisor or professional contact
- A brief letter of interest (no longer than one page) explaining why this opportunity interests you, what you hope to gain from it and how you plan to utilize the knowledge you obtain
All recipients are encouraged to attend the ACS Cancer Programs sessions scheduled for Saturday and Sunday, July 20–21. If you are interested in applying, please e-mail your letter of recommendation along with a summary of why you would like to attend to Danielle Lopez. Be sure to include your name, facility name, city, state, e-mail address and telephone number. The application deadline is April 30.
ACS committee opportunities
|
   |
The American College of Surgeons (ACS) Commission on Cancer (CoC) and Clinical Research Program (CRP) depend on volunteers from its diverse membership to drive the mission and initiatives of the organization and the surgical profession. Serving on a CoC or CRP committee is a great way to contribute to program initiatives, network with colleagues, advance into leadership positions and contribute to improvements in cancer patient care. The ACS Committee Opportunities web page includes information about those ACS committees, including the CoC and CRP, that are looking for new surgeon members to serve. Visit the ACS Committee Opportunities web page for details on what’s involved and how to apply. The deadline for applications is May 31, 2019.
|
SERVICE SHOWCASE | Advertisement
|
 |
|
Doctors Without Borders/Médecins Sans Frontières (MSF) is actively recruiting general and trauma surgeons with experience in emergency obstetrics for international missions in developing countries. Learn more
|
|
Register today for the 2019 ACS Quality and Safety Conference
|
   |
Registration for the 2019 ACS Quality and Safety Conference is now open. This year’s conference will be held in Washington, DC, July 19–22 at the Walter E. Washington Convention Center. For more information on the program agenda, meeting/events schedule, registration fees, lodging, transportation, preconference workshops and to review our official press release, please visit the Quality and Safety Conference website.
Cancer Programs staff on the road
|
   |
Make sure you meet the Cancer Programs staff at the Cancer Programs booth during the following conferences:
- American Society of Breast Surgeons (ASBS), April 30–May 5 in Dallas
- National Cancer Registrars Association (NCRA), May 19–22 in Denver
- ASCO Annual, May 31–June 4 in Chicago
- American Society for Colon and Rectal Surgeons, June 1–5 in Cleveland
Please stop by and learn what’s new from the Cancer Programs.
View the recording of the CAnswer Forum Live March 27 webinar
|
   |
If you were not able to participate in CAnswer Forum Live on March 27, you can access the recording of the webinar from the CAnswer Forum Live web page. In addition to the recording, you will also find a copy of the PowerPoint Presentation and other documents that were referenced during the webinar.
|
|
|
|
Advertisement
|
|
|
|
|
|
|
|
ACS CANCER PROGRAMS UPDATES |
ACS CRP Surgical Investigators Meeting at ASBrS
|
   |
The Alliance/American College of Surgeons Clinical Research Program will host a Surgical Investigators Meeting at the American Society of Breast Surgeons Annual Meeting. Please join us to hear about open and enrolling surgical oncology trials in breast cancer. The meeting will be held on Friday, May 3, from Noon - 1:00pm in the Coral Meeting Room at the Hilton Anatole in Dallas. Lunch will be provided. RSVP not required. For additional information, please contact Amanda Francescatti.
Tracking NCDB and RQRS Submissions on CoC Datalinks
|
   |
Hospital Registrars are encouraged to track the progress of their NCDB and RQRS submissions in CoC Datalinks NCDB Data Submission History and Edits and RQRS Data Submission History and Edits, respectively, to confirm the completeness and accuracy of their submission. From the NCDB Submission History Detail, select View Detail, then, select “View Edit Report” to show the edit report for each diagnosis year, as applicable. From the RQRS Submission History, select “View Detail for the file/s submitted, then, select the “View Edit Report” gray icon from the RQRS Edits Report or Records Rejected column to view the “RQRS Data Submission Edits Status.” The paragraph on the top of the page explains the failed edits with an edit score of 200 needs to be reviewed, corrected and resubmitted.
CTR Guide to Coding Radiation Therapy
|
   |
Until the next version of STORE reflecting the most recent updates is released, registrars are encouraged to use the CTR Guide to Coding Radiation Therapy Treatment in the STORE, which takes precedence over the current version of the STORE (v1.0).
The CTR Guide to Coding Radiation Therapy Treatment in the STORE may also be found in the Resources section of the National Cancer Database web page.
STORE Data Item Clarification for Coding I-131
|
   |
As referenced in page 10 of the CTR Guide to Coding Radiation Therapy Treatment in the STORE (Version 1.0), technically, I-131 is effective wherever there are thyroid cancer cells in the body, so there is no specific anatomic treatment volume involved. Therefore, it is recommended coding radioisotope treatments as 98 (Other). While another reasonable option would be to code the volume as 93 (Whole Body), code 93 (Whole Body) has traditionally been reserved for whole body treatment with external beam radiation such as is done prior to bone marrow transplantation. For historical consistency purposes, please use 98 (Other).
STORE is effective for cases diagnosed January 1, 2018. Use this manual for current cases. In most instances, it also should be used for historic cases being abstracted currently; exceptions are noted in the text.
Moving forward, please abstract cases following the rule from the STORE Data Item Clarification: I-131 for Thyroid for applicable cases. This includes cases diagnosed prior to 2018.
NCDB is not stating that thyroid cases diagnosed prior to 2018 should be pulled for review and re-coded to 98 (Other) if they had I-131.
For more details and the latest updates, please visit the Cancer Programs News page.
|
SPONSORED CONTENT | Advertisement
|
Promoted by
|
|
|
 |
HEALTH CARE NEWS AND UPDATES |
University of Zurich via ScienceDaily
Researchers have investigated the varying composition of cancer and immune cells in over one hundred breast tumors. They've found that aggressive tumors are often dominated by a single type of tumor cell. If certain immune cells are present as well, an immune therapy could be successful for a specific group of breast cancer patients.
READ MORE
Cancer Network via Modern Medicine
More than half of men who participated in an oncology clinical nurse specialist–led multidisciplinary prostate cancer clinic had reductions in distress scores, according to a small study. The OhioHealth Cancer Services Multidisciplinary Prostate Cancer Clinic meets on the third Thursday of every month and allows participating men to get a thorough second opinion on their disease; its goal is to educate, evaluate, and guide men on available treatments.
READ MORE
Harvard University
11,000 people are predicted to die from acute myeloid leukemia (AML) in 2019, according to the American Cancer Society. The cancer starts in the bone marrow. There, mutated genes fail to prevent blood cells from replicating again and again and again, growing tumors. Chemotherapy helps two out of three patients achieve remission. And recently, drug developers designed a new attack, one intended to target the patient’s malfunctioning genes, reclaim their hijacked cells, and halt growth.
READ MORE
 |
|
VTI’s Remotely Operated Suction Irrigation System (or “ROSI”) presents a new paradigm in suction and irrigation for robot-assisted procedures. The ROSI system gives the console surgeon complete control of suction and irrigation capabilities.
|
|
Health Imaging
CT colonography achieved a similar positive predictive value as colonoscopy during colon cancer screening and can help clinicians care for patients by specifying the nature of exam findings, according to a new study published in the American Journal of Roentgenology.
A trio of researchers from the U.S. and Italy set out to test the PPV for detecting colorectal lesions using only CTC compared to the commonly utilized stool-based tests such as the fecal immunochemical test.
READ MORE
Oncology Nurse Advisor
A comprehensive clinical orientation using evidence-based nurse residency program curriculum and rotations in various ambulatory services can improve new graduate nurse satisfaction, learning experience, and retention rates, as well as increase the competency of nurses in the ambulatory oncology setting. The findings were explained in a poster presentation at the Oncology Nursing Society 44th Annual Congress
READ MORE
UT Southwestern Medical Center via Medical Xpress
UT Southwestern researchers have found that a protein in the body's innate immune system that responds to gut microbes can suppress the most common type of liver cancer. The study, published today in the journal eLife, determined that NLRP12, an innate immune sensor, has a protective effect against hepatocellular carcinoma, a deadly human cancer associated with chronic inflammation. HCC is responsible for more than 80 percent of liver cancers in the U.S. It is the third-leading cause of cancer-related deaths worldwide and the ninth-leading cause in America, according to the National Cancer Institute.
READ MORE
News-Medical
Previously, the roots of many cancer have been unclear, with doctors unable to attribute the disease to any particular culprit among the myriad of carcinogens encountered by people every day in air pollution, pesticides, cigarette smoke, and sunlight, for example.
Even in the case of lung cancer, scientists have not been able to quantify the link between the cancer and smoking or other factors such as inhaling pollutants at work or living close to major road.
READ MORE
IMPORTANT DATES AND DEADLINES |
|
|
|
| The Brief
Connect with AJCC

Connect with CoC

Connect with NAPBC

Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the American College of Surgeons Cancer Programs from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The American College of Surgeons and Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs.
American College of Surgeons 633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|